Table 1.
Characteristics of patients/residents
| Total (N = 193) | Patients = 142 (73.6%) | Residents = 51 (26.4%) | ||||
|---|---|---|---|---|---|---|
| Variables [Missing] | N (%) | M (SD) | N (%) | M (SD) | N (%) | M (SD) |
| Age (yrs.) | 80.8 (7.8) | 79.1 (7.3) | 85.5 (7.5) | |||
| Sex (female) | 116 (60.1) | 76 (53.5) | 40 (78.4) | |||
| Diagnosis of dementia (yes) | 41 (21.2) | 5 (3.5) | 36 (70.6) | |||
| Types of dementia | ||||||
| Not specified | 3 (7.3) | 1 (20.0) | 2 (5.6) | |||
| Alzheimer | 12 (29.3) | 1 (20.0) | 11 (30.6) | |||
| Vascular | 4 (9.8) | 2 (40,0) | 2 (5.6) | |||
| Mixed | 19 (46.3) | 1 (20.0) | 18 (50.0) | |||
| Korsakoff | 3 (7.3) | 3 (8.3) | ||||
| DSM-IV-TR delirium | 23 (12) | 21 (14.8) | 2 (3.9) | |||
| Severity of cognitive impairment (HDS) [1] | 162.4 (50.9) | 178.6 (32.0) | 117.5 (65.0) | |||
| Mild (≥160) | 142 (74.0) | 123 (87.2) | 19 (37.3) | |||
| Moderate (between 40 and 160) | 39 (20.3) | 16 (11.4) | 23 (45.1) | |||
| Severe (≤40) | 11 (5.7) | 2 (1.4) | 9 (17.7) | |||
| Level of functional autonomy (SMAF) | 13.8 (11.6) | 9.6 (8.8) | 25.4 (10.7) | |||
| Mild <29 | 169 (87.6) | 138 (97.2) | 31 (60.8) | |||
| Moderate 29-40 | 19 (9.8) | 4 (2.8) | 15 (29.4) | |||
| Severe >40 | 5 (2.6) | 5 (9.8) | ||||
| Level of comorbidity: (CCI) | 6.1 (1.9) | 5.8 (1.9) | 6.8 (1.9) | |||
| Severe ≥ 8 | 37 (19.2) | 21 (14.8) | 16 (31.2) | |||
| Number of medications/day | 10.1 (3.9) | 10.1 (3.8) | 10.0 (4.3) | |||
| Number of distributions of meds/day | 3.6 (0.7) | 3.5 (0.7) | 3.6 (0.6) | |||
M (SD): Mean (standard deviation); HDS: Hierarchic Dementia Scale; SMAF: Functional Autonomy Measurement System; CCI: Charlson Comorbidity Index.